Crizotinib versus chemotherapy in advanced ALK-positive lung cancer
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
June 20, 2013
|
| In: |
The New England journal of medicine
Year: 2013, Jahrgang: 368, Pages: 2385-2394 |
| ISSN: | 1533-4406 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://www.nejm.org/doi/10.1056/NEJMoa1214886
|
| Verfasserangaben: | Alice T. Shaw, Dong-Wan Kim, Kazuhiko Nakagawa, Takashi Seto, Lucio Crinó, Myung-Ju Ahn, Tommaso De Pas, Benjamin Besse, Benjamin J. Solomon, Fiona Blackhall, Yi-Long Wu, Michael Thomas, Kenneth J. O'Byrne, Denis Moro-Sibilot, D. Ross Camidge, Tony Mok, Vera Hirsh, Gregory J. Riely, Shrividya Iyer, Vanessa Tassell, Anna Polli, Keith D. Wilner, and Pasi A. Jänne |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1787005534 | ||
| 003 | DE-627 | ||
| 005 | 20230428185140.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220124s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1056/NEJMoa1214886 |2 doi | |
| 035 | |a (DE-627)1787005534 | ||
| 035 | |a (DE-599)KXP1787005534 | ||
| 035 | |a (OCoLC)1341439144 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Shaw, Alice T. |e VerfasserIn |0 (DE-588)1217066543 |0 (DE-627)1728864860 |4 aut | |
| 245 | 1 | 0 | |a Crizotinib versus chemotherapy in advanced ALK-positive lung cancer |c Alice T. Shaw, Dong-Wan Kim, Kazuhiko Nakagawa, Takashi Seto, Lucio Crinó, Myung-Ju Ahn, Tommaso De Pas, Benjamin Besse, Benjamin J. Solomon, Fiona Blackhall, Yi-Long Wu, Michael Thomas, Kenneth J. O'Byrne, Denis Moro-Sibilot, D. Ross Camidge, Tony Mok, Vera Hirsh, Gregory J. Riely, Shrividya Iyer, Vanessa Tassell, Anna Polli, Keith D. Wilner, and Pasi A. Jänne |
| 264 | 1 | |c June 20, 2013 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 24.01.2022 | ||
| 700 | 1 | |a Kim, Dong-Wan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nakagawa, Kazuhiko |e VerfasserIn |4 aut | |
| 700 | 1 | |a Seto, Takashi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Crinó, Lucio |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ahn, Myung-Ju |e VerfasserIn |4 aut | |
| 700 | 1 | |a De Pas, Tommaso |e VerfasserIn |4 aut | |
| 700 | 1 | |a Besse, Benjamin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Solomon, Benjamin J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Blackhall, Fiona |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wu, Yi-Long |e VerfasserIn |4 aut | |
| 700 | 1 | |a Thomas, Michael |e VerfasserIn |0 (DE-588)1054438781 |0 (DE-627)79152213X |0 (DE-576)41027089X |4 aut | |
| 700 | 1 | |a O'Byrne, Kenneth J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Moro-Sibilot, Denis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Camidge, D. Ross |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mok, Tony |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hirsh, Vera |e VerfasserIn |4 aut | |
| 700 | 1 | |a Riely, Gregory J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Iyer, Shrividya |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tassell, Vanessa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Polli, Anna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wilner, Keith D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jänne, Pasi A. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d Waltham, Mass. : MMS, 1928 |g 368(2013) vom: 20. Juni, Seite 2385-2394 |h Online-Ressource |w (DE-627)266889484 |w (DE-600)1468837-2 |w (DE-576)075962454 |x 1533-4406 |7 nnas |a Crizotinib versus chemotherapy in advanced ALK-positive lung cancer |
| 773 | 1 | 8 | |g volume:368 |g year:2013 |g day:20 |g month:06 |g pages:2385-2394 |g extent:10 |a Crizotinib versus chemotherapy in advanced ALK-positive lung cancer |
| 856 | 4 | 0 | |u https://www.nejm.org/doi/10.1056/NEJMoa1214886 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220124 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 1054438781 |a Thomas, Michael |m 1054438781:Thomas, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PT1054438781 |e 950000PT1054438781 |e 950900PT1054438781 |e 50000PT1054438781 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 11 | ||
| 999 | |a KXP-PPN1787005534 |e 4042251129 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"10 S."}],"recId":"1787005534","relHost":[{"name":{"displayForm":["Massachusetts Medical Society"]},"disp":"Crizotinib versus chemotherapy in advanced ALK-positive lung cancerThe New England journal of medicine","title":[{"title_sort":"New England journal of medicine","title":"The New England journal of medicine","subtitle":"NEJM"}],"part":{"text":"368(2013) vom: 20. Juni, Seite 2385-2394","year":"2013","volume":"368","pages":"2385-2394","extent":"10"},"id":{"zdb":["1468837-2"],"eki":["266889484"],"issn":["1533-4406"]},"origin":[{"dateIssuedDisp":"1928-","publisher":"MMS ; MMS","dateIssuedKey":"1928","publisherPlace":"Waltham, Mass. ; Boston, Mass."}],"language":["eng"],"pubHistory":["198.1928 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"NEJM"}],"corporate":[{"role":"isb","display":"Massachusetts Medical Society"}],"note":["Gesehen am 04.08.25"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"266889484"}],"language":["eng"],"note":["Gesehen am 24.01.2022"],"id":{"doi":["10.1056/NEJMoa1214886"],"eki":["1787005534"]},"person":[{"given":"Alice T.","family":"Shaw","display":"Shaw, Alice T.","role":"aut"},{"given":"Dong-Wan","family":"Kim","role":"aut","display":"Kim, Dong-Wan"},{"given":"Kazuhiko","display":"Nakagawa, Kazuhiko","role":"aut","family":"Nakagawa"},{"given":"Takashi","family":"Seto","display":"Seto, Takashi","role":"aut"},{"given":"Lucio","family":"Crinó","display":"Crinó, Lucio","role":"aut"},{"given":"Myung-Ju","role":"aut","display":"Ahn, Myung-Ju","family":"Ahn"},{"family":"De Pas","display":"De Pas, Tommaso","role":"aut","given":"Tommaso"},{"family":"Besse","role":"aut","display":"Besse, Benjamin","given":"Benjamin"},{"given":"Benjamin J.","family":"Solomon","display":"Solomon, Benjamin J.","role":"aut"},{"given":"Fiona","role":"aut","display":"Blackhall, Fiona","family":"Blackhall"},{"given":"Yi-Long","role":"aut","display":"Wu, Yi-Long","family":"Wu"},{"given":"Michael","family":"Thomas","display":"Thomas, Michael","role":"aut"},{"family":"O'Byrne","role":"aut","display":"O'Byrne, Kenneth J.","given":"Kenneth J."},{"given":"Denis","display":"Moro-Sibilot, Denis","role":"aut","family":"Moro-Sibilot"},{"given":"D. Ross","family":"Camidge","display":"Camidge, D. Ross","role":"aut"},{"display":"Mok, Tony","role":"aut","family":"Mok","given":"Tony"},{"given":"Vera","display":"Hirsh, Vera","role":"aut","family":"Hirsh"},{"given":"Gregory J.","family":"Riely","role":"aut","display":"Riely, Gregory J."},{"given":"Shrividya","family":"Iyer","role":"aut","display":"Iyer, Shrividya"},{"role":"aut","display":"Tassell, Vanessa","family":"Tassell","given":"Vanessa"},{"given":"Anna","family":"Polli","role":"aut","display":"Polli, Anna"},{"display":"Wilner, Keith D.","role":"aut","family":"Wilner","given":"Keith D."},{"given":"Pasi A.","role":"aut","display":"Jänne, Pasi A.","family":"Jänne"}],"origin":[{"dateIssuedDisp":"June 20, 2013","dateIssuedKey":"2013"}],"title":[{"title":"Crizotinib versus chemotherapy in advanced ALK-positive lung cancer","title_sort":"Crizotinib versus chemotherapy in advanced ALK-positive lung cancer"}],"name":{"displayForm":["Alice T. Shaw, Dong-Wan Kim, Kazuhiko Nakagawa, Takashi Seto, Lucio Crinó, Myung-Ju Ahn, Tommaso De Pas, Benjamin Besse, Benjamin J. Solomon, Fiona Blackhall, Yi-Long Wu, Michael Thomas, Kenneth J. O'Byrne, Denis Moro-Sibilot, D. Ross Camidge, Tony Mok, Vera Hirsh, Gregory J. Riely, Shrividya Iyer, Vanessa Tassell, Anna Polli, Keith D. Wilner, and Pasi A. Jänne"]},"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a SHAWALICETCRIZOTINIB2020 | ||